Interferon-Induced Depression in Chronic Hepatitis C: A Systematic Review and Meta-Analysis
The DOI matches its Crossref record; 70 of the 70 references it cites were found in a registry or an index.
Abstract
OBJECTIVE: To carry out a systematic review of the risk factors for, and incidence of, major depressive episode (MDE) related to antiviral therapy for chronic hepatitis C. DATA SOURCES: The MEDLINE, PsycINFO, and Cochrane databases were searched to locate articles published from the earliest available online year until June 2011 using the keywords hepatitis C, interferon-alpha, peginterferon, pegylated interferon, depression, and mood and Boolean operators. Articles written in English, Spanish, and French were included. STUDY SELECTION: Prospective studies reporting incidence of interferon-alpha-induced MDE were included. At baseline, patients did not present a DSM-IV/ICD depressive episode, and evaluation was performed by a trained clinician. Twenty-six observational studies met the inclusion criteria. DATA EXTRACTION: Extracted data included authors, year of publication, design, characteristics of the population, viral coinfection, adjunctive psychopharmacology, instruments to assess depression, dose and type of interferon-alpha, adjunctive ribavirin treatment, and follow-up time. Outcome of incidence of MDE (primary outcome measure) was abstracted, as were potential predictive variables. DATA SYNTHESIS: A full review was performed. Meta-analysis of the cumulative incidence of induced MDE as a function of time was carried out. Odds ratios (ORs) and mean differences were used to estimate the strength of association of variables. RESULTS: Overall cumulative incidence of depression was 0.25 (95% CI, 0.16 to 0.35) and 0.28 (95% CI, 0.17 to 0.42) at 24 and 48 weeks of treatment, respectively. According to our analysis, high baseline levels of interleukin 6 (mean difference = 1.81; 95% CI, 1.09 to 2.52), female gender (OR = 1.40; 95% CI, 1.02 to 1.91), history of MDE (OR = 3.96; 95% CI, 2.52 to 6.21), history of psychiatric disorder (OR = 3.18; 95% CI, 1.60 to 6.32), subthreshold depressive symptoms (mean difference = 0.96; 95% CI, 0.31 to 1.61), and low educational level (mean difference = -0.99; 95% CI, -1.59 to -0.39) were predictive variables of MDE during antiviral treatment. CONCLUSIONS: One in 4 chronic hepatitis C patients who start interferon and ribavirin treatment will develop an induced major depressive episode. Clinicians should attempt a full evaluation of patients before starting antiviral treatment in order to identify those at risk of developing interferon-induced depression.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Women also exhibit a greater likelihood than men to develop depression in response to standardized doses of interferon-α (IFNα)12.”
From The role of inflammation in depression: from evolutionary imperative to modern treatment target (2016) · cites this paper as [12]
In the citing paper
“A well-known example is interferon or IL-2 treatment, in which up to 80% of individuals develop depressive symptoms, often dominated by somatic/neurovegetative manifestations within the first weeks, and 25% develop a major depressive episode within 48 weeks343.”
From Comorbidity between major depressive disorder and physical diseases: a comprehensive review of epidemiology, mechanisms and management (2023) · cites this paper as [343]
In the citing paper
“a recent meta-analysis estimates that ~ 25% of patients with chronic hepatitis C develop depression after treatment with the proinflammatory cytokine interferon-α (IFN-α) (12).”
From Peripheral cytokine and chemokine alterations in depression: a meta‐analysis of 82 studies (2017) · cites this paper as [12]
Citations
Cites
Bias in meta-analysis detected by a simple, graphical test
Egger, M., Smith, G. D., Schneider, M., & Minder, C. (1997) · BMJ · doi:10.1136/bmj.315.7109.629 · Cited by 56,722
Meta-analysis in clinical trials
DerSimonian, R., & Laird, N. (1986) · Controlled Clinical Trials · doi:10.1016/0197-2456(86)90046-2 · Cited by 39,552
Meta-analysis of Observational Studies in Epidemiology<SUBTITLE>A Proposal for Reporting</SUBTITLE>
Stroup, D. F. (2000) · JAMA · doi:10.1001/jama.283.15.2008 · Cited by 20,623
(2014) · Medical Entomology and Zoology · Cited by 17,633
Operating characteristics of a rank correlation test for publication bias
Begg, C. B., & Mazumdar, M. (1994) · Biometrics · doi:10.2307/2533446 · Cited by 16,955
Vandenbroucke, J. P., von Elm, E., Altman, D. G., Gøtzsche, P. C., Mulrow, C. D., Pocock, S. J., Poole, C., Schlesselman, J. J., Egger, M., & Initiative, F. T. S. (2007) · PLoS Medicine · doi:10.1371/journal.pmed.0040297 · Cited by 8,613
Peginterferon Alfa-2a plus Ribavirin for Chronic Hepatitis C Virus Infection
Fried, M. W., Shiffman, M. L., Reddy, K. R., Smith, C., Marinos, G., Gonçales, F. L., Häussinger, D., Diago, M., Carosi, G., Dhumeaux, D., et al. (2002) · New England Journal of Medicine · doi:10.1056/nejmoa020047 · Cited by 6,389
Manns, M. P., McHutchison, J. G., Gordon, S. C., Rustgi, V. K., Shiffman, M., Reindollar, R., Goodman, Z. D., Koury, K., Ling, M.-H., & Albrecht, J. K. (2001) · The Lancet · doi:10.1016/s0140-6736(01)06102-5 · Cited by 6,029
A Meta-Analysis of Cytokines in Major Depression
Dowlati, Y., Herrmann, N., Swardfager, W., Liu, H., Sham, L., Reim, E. K., & Lanctôt, K. L. (2010) · Biological Psychiatry · doi:10.1016/j.biopsych.2009.09.033 · Cited by 4,729
Vandenbroucke, J. P., Elm, E. V., Altman, D. G., Gøtzsche, P. C., Mulrow, C. D., Pocock, S. J., Poole, C., Schlesselman, J. J., Egger, M., & initiative, F. T. S. (2007) · Annals of Internal Medicine · doi:10.7326/0003-4819-147-8-200710160-00010-w1 · Cited by 3,543
McHutchison, J. G., Gordon, S. C., Schiff, E. R., Shiffman, M. L., Lee, W. M., Rustgi, V. K., Goodman, Z. D., Ling, M.-H., Cort, S., & Albrecht, J. K. (1998) · New England Journal of Medicine · doi:10.1056/nejm199811193392101 · Cited by 3,465
Cytokines sing the blues: inflammation and the pathogenesis of depression
Raison, C. L., Capuron, L., & Miller, A. H. (2006) · Trends in Immunology · doi:10.1016/j.it.2005.11.006 · Cited by 3,009
Telaprevir for Previously Untreated Chronic Hepatitis C Virus Infection
Jacobson, I. M., McHutchison, J. G., Dusheiko, G., Di Bisceglie, A. M., Reddy, K. R., Bzowej, N. H., Marcellin, P., Muir, A. J., Ferenci, P., Flisiak, R., et al. (2011) · New England Journal of Medicine · doi:10.1056/nejmoa1012912 · Cited by 2,398
Cytokines and major depression
Schiepers, O. J. G., Wichers, M. C., & Maes, M. (2005) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2004.11.003 · Cited by 1,235
Epidemiology of Hepatitis C: Geographic Differences and Temporal Trends
Wasley, A., & Alter, M. J. (2000) · Seminars in Liver Disease · doi:10.1055/s-2000-9506 · Cited by 979
Cytokine-induced sickness behavior: where do we stand?
Dantzer, R. (2001) · Brain, Behavior, and Immunity · doi:10.1006/brbi.2000.0613 · Cited by 862
Gender differences in depression
Parker, G., & Brotchie, H. (2010) · International Review of Psychiatry · doi:10.3109/09540261.2010.492391 · Cited by 756
Kwo, P. Y., Lawitz, E. J., McCone, J., Schiff, E. R., Vierling, J. M., Pound, D., Davis, M. N., Galati, J. S., Gordon, S. C., Ravendhran, N., et al. (2010) · The Lancet · doi:10.1016/s0140-6736(10)60934-8 · Cited by 704
Gaynes, B. N., Warden, D., Trivedi, M. H., Wisniewski, S. R., Fava, M., & Rush, A. J. (2009) · Psychiatric Services · doi:10.1176/ps.2009.60.11.1439 · Cited by 661
A systematic review of hepatitis C virus epidemiology in Asia, Australia and Egypt
Sievert, W., Altraif, I., Razavi, H. A., Abdo, A., Ahmed, E. A., AlOmair, A., Amarapurkar, D., Chen, C., Dou, X., El Khayat, H., et al. (2011) · Liver International · doi:10.1111/j.1478-3231.2011.02540.x · Cited by 534
Poynard, T., McHutchison, J., Goodman, Z., Ling, M.-H., & Albrecht, J. (2000) · Hepatology · doi:10.1002/hep.510310131 · Cited by 368
Mechanism of action of ribavirin in the combination treatment of chronic HCV infection
Lau, J. Y. N., Tam, R. C., Liang, J. T., & Hong, Z. (2002) · Hepatology · doi:10.1053/jhep.2002.32672 · Cited by 337
Hauser, P., Khosla, J., Aurora, H., Laurin, J., Kling, M. A., Hill, J., Gulati, M., Thornton, A. J., Schultz, R. L., Valentine, A. D., et al. (2002) · Molecular Psychiatry · doi:10.1038/sj.mp.4001119 · Cited by 313
Anisman, H. (2009) · Journal of Psychiatry and Neuroscience · doi:10.1139/jpn.0902 · Cited by 292
Depression induced by treatment with interferon-alpha in patients affected by hepatitis C virus
Bonaccorso, S., Marino, V., Biondi, M., Grimaldi, F., Ippoliti, F., & Maes, M. (2002) · Journal of Affective Disorders · doi:10.1016/s0165-0327(02)00264-1 · Cited by 284
Epidemiologic Methods: Studying the Occurrence of Illness
Koepsell, T. D., & Weiss, N. S. (2014) · Cited by 258
Psychiatric Symptoms in Patients With Chronic Hepatitis C Receiving Interferon Alfa-2b Therapy
Kraus, M. R., Schafer, A., Faller, H., Csef, H., & Scheurlen, M. (2003) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v64n0614 · Cited by 245
Raison, C. L., Borisov, A. S., Woolwine, B. J., Massung, B., Vogt, G., & Miller, A. H. (2010) · Molecular Psychiatry · doi:10.1038/mp.2008.58 · Cited by 183
Appendix: The National Institutes of Health Consensus Development Conference
Seeff, L. B., & Hoofnagle, J. H. (2003) · Clinics in Liver Disease · doi:10.1016/s1089-3261(02)00078-8 · Cited by 174
Paroxetine for the treatment of interferon‐α‐induced depression in chronic hepatitis C
Kraus, M. R., Schäfer, A., Faller, H., Csef, H., & Scheurlen, M. (2002) · Alimentary Pharmacology & Therapeutics · doi:10.1046/j.1365-2036.2002.01265.x · Cited by 170
Su, K.-P., Huang, S.-Y., Peng, C.-Y., Lai, H.-C., Huang, C.-L., Chen, Y.-C., Aitchison, K. J., & Pariante, C. M. (2010) · Biological Psychiatry · doi:10.1016/j.biopsych.2009.11.005 · Cited by 165
RAISON, C. L., WOOLWINE, B. J., DEMETRASHVILI, M. F., BORISOV, A. S., WEINREIB, R., STAAB, J. P., ZAJECKA, J. M., BRUNO, C. J., HENDERSON, M. A., REINUS, J. F., et al. (2007) · Alimentary Pharmacology & Therapeutics · doi:10.1111/j.1365-2036.2007.03316.x · Cited by 142
Depression, anemia and health-related quality of life in chronic hepatitis C
Dan, A. A., Martin, L. M., Crone, C., Ong, J. P., Farmer, D. W., Wise, T. N., Robbins, S., & Younossi, Z. M. (2005) · Journal of Hepatology · doi:10.1016/j.jhep.2005.11.046 · Cited by 141
Horikawa, N., Yamazaki, T., Izumi, N., & Uchihara, M. (2003) · General Hospital Psychiatry · doi:10.1016/s0163-8343(02)00239-6 · Cited by 140
Cytokine-induced depression during IFN-α treatment: The role of IL-6 and sleep quality
Prather, A. A., Rabinovitz, M., Pollock, B. G., & Lotrich, F. E. (2009) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2009.07.001 · Cited by 139
Lotrich, F. E., Ferrell, R. E., Rabinovitz, M., & Pollock, B. G. (2009) · Biological Psychiatry · doi:10.1016/j.biopsych.2008.08.009 · Cited by 136
Depression From Interferon Therapy in Patients With Hepatitis C
Miyaoka, H., Otsubo, T., Kamijima, K., Ishii, M., ONUKI, M., & Mitamura, K. (1999) · American Journal of Psychiatry · doi:10.1176/ajp.156.7.1120 · Cited by 135
Depression following pegylated interferon-alpha: Characteristics and vulnerability
Lotrich, F. E., Rabinovitz, M., Gironda, P., & Pollock, B. G. (2007) · Journal of Psychosomatic Research · doi:10.1016/j.jpsychores.2007.05.013 · Cited by 100
Schiepers, O. J. G., Wichers, M., & Maes, M. H. J. (2005) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2005.02.001 · Cited by 97
Leone, N., & Rizzetto, M. (2005) · PubMed · Cited by 92
Wichers, M., Kenis, G., Leue, C., Koek, G. H., Robaeys, G., & Maes, M. H. J. (2006) · Biological Psychiatry · doi:10.1016/j.biopsych.2005.11.024 · Cited by 92
Smith, A. K., Simon, J. S., Gustafson, E. L., Noviello, S., Cubells, J. F., Epstein, M. P., Devlin, D. J., Qiu, P., Albrecht, J. K., Brass, C. A., et al. (2012) · Molecular Psychiatry · doi:10.1038/mp.2011.67 · Cited by 84
Early increase in vegetative symptoms predicts IFN-α-induced cognitive-depressive changes
WICHERS, M. C., KOEK, G. H., ROBAEYS, G., PRAAMSTRA, A. J., & MAES, M. (2005) · Psychological Medicine · doi:10.1017/s0033291704003526 · Cited by 84
MARTÍN‐SANTOS, R., DÍEZ‐QUEVEDO, C., CASTELLVÍ, P., NAVINÉS, R., MIQUEL, M., MASNOU, H., SOLER, A., ARDEVOL, M., GARCÍA, F., GALERAS, J. A., et al. (2008) · Alimentary Pharmacology & Therapeutics · doi:10.1111/j.1365-2036.2007.03568.x · Cited by 79
Self-citationPrevalencia de las hepatitis B y C en diversas comarcas de Cataluña: estudio transversal
Sola, R. L., de Castro, E. C., Hombrados, M., Planas, R., Coll, S., Jardí, R., Sunyer, J., Covas, M. I., & Marrugat, J. (2002) · Medicina Clínica · doi:10.1016/s0025-7753(02)73328-9 · Cited by 70
Franzen, P. L., Buysse, D. J., Rabinovitz, M., Pollock, B. G., & Lotrich, F. E. (2010) · Psychiatry Research · doi:10.1016/j.psychres.2009.02.011 · Cited by 62
Mood, cognition and EEG changes during interferon α (alpha-IFN) treatment for chronic hepatitis C
Amodio, P., De Toni, E. N., Cavalletto, L., Mapelli, D., Bernardinello, E., Del Piccolo, F., Bergamelli, C., Costanzo, R., Bergamaschi, F., Poma, S. Z., et al. (2005) · Journal of Affective Disorders · doi:10.1016/j.jad.2004.09.004 · Cited by 61
CASTERA, L., CONSTANT, A., HENRY, C., CHAMPBENOIT, P., BERNARD, P. ‐., DE LEDINGHEN, V., DEMOTES‐MAINARD, J., & COUZIGOU, P. (2006) · Alimentary Pharmacology & Therapeutics · doi:10.1111/j.1365-2036.2006.03107.x · Cited by 59
Neuropsychiatric Effects and Type of IFN-α in Chronic Hepatitis C
Malaguarnera, M., Laurino, A., Di Fazio, I., Pistone, G., Castorina, M., Guccione, N., & Rampello, L. (2001) · Journal of Interferon & Cytokine Research · doi:10.1089/107999001300177457 · Cited by 57
Schäfer, A., Wittchen, H., Seufert, J., & Kraus, M. R. (2007) · International Journal of Methods in Psychiatric Research · doi:10.1002/mpr.229 · Cited by 52
Russo, S., Kema, I. P., Haagsma, E. B., Boon, J. C., Willemse, P. H. B., den Boer, J. A., de Vries, E. G. E., & Korf, J. (2005) · Psychosomatic Medicine · doi:10.1097/01.psy.0000171193.28044.d8 · Cited by 48
Diez-Quevedo, C., Masnou, H., Planas, R., Castellví, P., Giménez, D., Morillas, R. M., Martín-Santos, R., Navinés, R., Solà, R., Giner, P., et al. (2011) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.09m05282blu · Cited by 45
Self-citationA Consensus Statement for Safety Monitoring Guidelines of Treatments for Major Depressive Disorder
Dodd, S., Malhi, G. S., Tiller, J., Schweitzer, I., Hickie, I., Khoo, J. P., Bassett, D. L., Lyndon, B., Mitchell, P. B., Parker, G., et al. (2011) · Australian & New Zealand Journal of Psychiatry · doi:10.3109/00048674.2011.595686 · Cited by 45
Self-citationIncidence of interferon alfa-induced depression in patients with chronic hepatitis C
Castéra, L., Zigante, F., Bastie, A., Buffet, C., Dhumeaux, D., & Hardy, P. (2002) · Hepatology · doi:10.1053/jhep.2002.32104 · Cited by 44
Fontana, R. J., Kronfol, Z., Lindsay, K. L., Bieliauskas, L. A., Padmanabhan, L., Back-Madruga, C., Lok, A. S. F., Stoddard, A. M., & the HALT-C Trial Group (2008) · The American Journal of Gastroenterology · doi:10.1111/j.1572-0241.2008.02106.x · Cited by 43
Personality disorder and the Temperament and Character Inventory in the elderly
Casey, J., & Joyce, P. R. (1999) · Acta Psychiatrica Scandinavica · doi:10.1111/j.1600-0447.1999.tb10865.x · Cited by 41
Lotrich, F. E., Ferrell, R. E., Rabinovitz, M., & Pollock, B. G. (2010) · Clinical Neuropharmacology · doi:10.1097/wnf.0b013e3181de8966 · Cited by 41
Suicidal Ideation With IFN-α and Ribavirin in a Patient With Hepatitis C
Ademmer, K., Beutel, M. E., Bretzel, R. G., Clemens, J., & Reimer, C. (2001) · Psychosomatics · doi:10.1176/appi.psy.42.4.365 · Cited by 37
Neri, S., Bertino, G., Petralia, A., Giancarlo, C., Rizzotto, A., Calvagno, G. S., Mauceri, B., Abate, G., Boemi, P., Di Pino, A., et al. (2010) · Journal of Clinical Gastroenterology · doi:10.1097/mcg.0b013e3181d88af5 · Cited by 37
Lotrich, F. E., Loftis, J. M., Ferrell, R. E., Rabinovitz, M., & Hauser, P. (2011) · Journal of Interferon & Cytokine Research · doi:10.1089/jir.2010.0074 · Cited by 35
Dell’Osso, L., Pini, S., Maggi, L., Rucci, P., Debbio, A. D., Carlini, M., Baldini, A., Ferrari, G., Manca, E., Beverini, E., et al. (2007) · Journal of Psychosomatic Research · doi:10.1016/j.jpsychores.2006.10.024 · Cited by 35
Maekawa, S., & Enomoto, N. (2009) · Journal of Gastroenterology · doi:10.1007/s00535-009-0126-7 · Cited by 35
Quarantini, L. C., Bressan, R. A., Galvão, A., Batista-Neves, S. C., Paraná, R., & Miranda‐Scippa, Â. (2007) · Liver International · doi:10.1111/j.1478-3231.2007.01532.x · Cited by 33
Pegylated Interferon and Ribavirin-Induced Depression in Chronic Hepatitis C
Castellví, P., Navinés, R., Gutiérrez, F., Jiménez, D., Márquez, C., Subirà, S., Sola, R. L., & Martín‐Santos, R. (2009) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.08m04230 · Cited by 32
Self-citationTse, W. S., Rochelle, T. L., & Cheung, J. C. K. (2011) · International Journal of Psychology · doi:10.1080/00207594.2011.554553 · Cited by 19
Pawełczyk, T., Pawełczyk, A. M., Strzelecki, D., & Rabe‐Jabłońska, J. (2008) · General Hospital Psychiatry · doi:10.1016/j.genhosppsych.2008.03.001 · Cited by 17
Schäfer, A., Scheurlen, M., Weißbrich, B., Schöttker, K., & Kraus, M. R. (2007) · Chemotherapy · doi:10.1159/000102584 · Cited by 16
Robaeys, G. (2007) · World Journal of Gastroenterology · doi:10.3748/wjg.v13.i43.5736 · Cited by 15
Diagnosing and treating hepatitis C virus infection.
Schiff, E. R. (2011) · PubMed · Cited by 12
Solà, R., Castro, E., & Hombrados, M. (2002) · Medicina Clínica · Cited by 9
Self-citation
Cited by
The role of inflammation in depression: from evolutionary imperative to modern treatment target
Miller, A. H., & Raison, C. L. (2016) · Nature Reviews Immunology · doi:10.1038/nri.2015.5 · Cited by 3,942
Peripheral cytokine and chemokine alterations in depression: a meta‐analysis of 82 studies
Köhler, C. A., Freitas, T. H., Maes, M., de Andrade, N. Q., Liu, C. S., Fernandes, B. S., Stubbs, B., Solmi, M., Veronese, N., Herrmann, N., et al. (2017) · Acta Psychiatrica Scandinavica · doi:10.1111/acps.12698 · Cited by 1,443
So depression is an inflammatory disease, but where does the inflammation come from?
Berk, M., Williams, L. J., Jacka, F. N., O’Neil, A., Pasco, J. A., Moylan, S., Allen, N. B., Stuart, A. L., Hayley, A. C., Byrne, M. L., et al. (2013) · BMC Medicine · doi:10.1186/1741-7015-11-200 · Cited by 1,423
“As an exemplar, a quarter of the people given interferon for the treatment of hepatitis C develop emergent major depression [8,9].”
Psychobiotics: A novel class of psychotropic
Dinan, T. G., Stanton, C., & Cryan, J. F. (2013) · Biological Psychiatry · doi:10.1016/j.biopsych.2013.05.001 · Cited by 1,287
“can be prevented by antidepressant therapy (51,52).”
Psychobiotics and the manipulation of bacteria–gut–brain signals
Sarkar, A., Lehto, S. M., Harty, S., Dinan, T. G., Cryan, J. F., & Burnet, P. W. J. (2016) · Trends in Neurosciences · doi:10.1016/j.tins.2016.09.002 · Cited by 1,068
“For example, injection of interferon-/, a pro-inflammatory cytokine, has been shown to induce depression, which can be alleviated through antidepressant action [14,15].”
Metadata
- Authors
- Udina, M., Castellví, P., Moreno-España, J., Navinés, R., Valdés, M., Forns, X., Langohr, K., Solà, R., Vieta, E., & Martín-Santos, R.
- Affiliations
- Centro de Investigación Biomédica en Red de Salud Mental (ES)
- Venue
- The Journal of Clinical Psychiatry
- Publisher
- Physicians Postgraduate Press, Inc
- Published
- 2012-08-15
- Volume
- 73
- Issue
- 08
- Pages
- 1128-1138
- ISSN
- 0160-6689 (ISSN-L)
- OpenAlex
- W1981407617
- Cited by
- 297
- References
- 70
- Citations by year
- 2026: 9 · 2025: 15 · 2024: 11 · 2023: 17 · 2022: 20 · 2021: 20 · 2020: 19 · 2019: 27 · 2018: 22 · 2017: 26 · 2016: 28 · 2015: 33 · 2014: 30 · 2013: 16 · 2012: 2
- FWCI
- 16.41
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- The Journal of Clinical Psychiatry (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Hepatology › Hepatitis C virus research
- Life Sciences › Neuroscience › Biological Psychiatry › Tryptophan and brain disorders
- Health Sciences › Medicine › Pharmacology (medical) › Treatment of Major Depression
- Keywords
- chronic hepatitis C, interferon-alpha, pegylated interferon, depression, major depressive episode, antiviral therapy adverse effects, interleukin-6, risk factors, ribavirin, psychiatric comorbidity, subthreshold depression, depression incidence, treatment discontinuation, viral coinfection, educational attainment, female sex, history of depression
- MeSH terms
- Interferon alpha-2, Antiviral Agents, Cross-Sectional Studies, Major Depressive Disorder, Female, Humans, Polyethylene Glycols, Prospective Studies, Recombinant Proteins, Risk Factors, Incidence, Interferon-alpha, Hepatitis C, Chronic
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.